Cargando…
Feasibility of Polyclonal Avian Immunoglobulins (IgY) as Prophylaxis against Human Norovirus Infection
Background: Human norovirus (HuNoV) is the leading viral cause of diarrhea, with GII.4 as the predominant genotype of HuNoV outbreaks globally. However, new genogroup variants emerge periodically, complicating the development of anti-HuNoV vaccines; other prophylactic or therapeutic medications spec...
Autores principales: | Artman, Chad, Idegwu, Nnebuefe, Brumfield, Kyle D., Lai, Ken, Hauta, Shirley, Falzarano, Darryl, Parreño, Viviana, Yuan, Lijuan, Geyer, James D., Goepp, Julius G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698945/ https://www.ncbi.nlm.nih.gov/pubmed/36366469 http://dx.doi.org/10.3390/v14112371 |
Ejemplares similares
-
Feasibility of avian antibodies as prophylaxis against enterotoxigenic escherichia coli colonization
por: Brumfield, Kyle, et al.
Publicado: (2022) -
Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication
por: Artman, Chad, et al.
Publicado: (2021) -
A Taxonomy-Agnostic Approach to Targeted Microbiome Therapeutics—Leveraging Principles of Systems Biology
por: Brumfield, Kyle D., et al.
Publicado: (2023) -
Polyclonal immunoglobulins for COVID-19 pre-exposure prophylaxis in immunocompromised patients
por: Focosi, Daniele, et al.
Publicado: (2023) -
Anti-SpCas9 IgY
Polyclonal Antibodies Production for
CRISPR Research Use
por: León, Esteban, et al.
Publicado: (2023)